Where to invest $50,000 in ASX shares

Analysts think these shares could be great destinations for your hard-earned money.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you are lucky enough to be sitting on $50,000 and wondering how to put it to work in the share market, then read on.

With interest rates falling and long-term growth back in focus, now could be a great time to build a high-quality ASX share portfolio aimed at capital appreciation.

But rather than chasing short-term trades or speculative names, investors may want to consider businesses with proven track records, strong global expansion, and resilient earnings.

With that in mind, here are five standout ASX shares that analysts think could form the foundation of a smart, long-term portfolio. They are as follows:

A happy young couple lie on a wooden deck using a skateboard for a pillow.

Image source: Getty Images

Cochlear Ltd (ASX: COH)

Cochlear is a global leader in hearing implants technology. With an ageing global population and rising rates of hearing loss, demand for Cochlear's products is only expected to increase over the next decade. The company also invests heavily in R&D, which keeps it ahead of the pack with next-generation devices.

Last week, UBS upgraded its shares to a buy rating with a $325.00 price target.

REA Group Ltd (ASX: REA)

Another ASX share to look at with the $50,000 is REA Group. It is the name behind realestate.com.au, which dominates the online property advertising space in Australia. While the housing market moves in cycles, REA Group has built an incredibly sticky platform with pricing power and deep competitive moats.

Bell Potter is bullish on REA Group and has a buy rating and $267.00 price target on its shares.

ResMed Inc. (ASX: RMD)

ResMed is a major player in the treatment of obstructive sleep apnoea and other sleep and breathing disorders. While concerns around weight-loss drugs spooked the market last year, ResMed has continued to post strong results, including robust mask sales, margin expansion, and double-digit earnings growth. It also benefits from an ageing population and increasing awareness of sleep health.

Macquarie has an outperform rating and $48.00 price target on this ASX share.

WiseTech Global Ltd (ASX: WTC)

WiseTech could be an ASX share to buy with the $50,000. It is a global logistics software provider, best known for its CargoWise platform. It serves some of the world's largest freight forwarders and is capitalising on the structural shift toward digital supply chain management. Recurring revenue, global customer wins, and ongoing product innovation give WiseTech a long runway for growth.

The team at Macquarie has an outperform rating and $152.70 price target on its shares.

Xero Ltd (ASX: XRO)

Finally, Xero could be worth considering. It offers cloud-based accounting software to small and medium-sized businesses. It is one of the most recognisable tech names in the region, with a sticky, subscription-based model and strong international growth potential. And with 4.4 million subscribers on its platform and an estimated 100 million total addressable market, it still has a very long growth runway.

Morgan Stanley has an overweight rating and $220.00 price target on its shares.

Motley Fool contributor James Mickleboro has positions in Cochlear, REA Group, ResMed, WiseTech Global, and Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Cochlear, Macquarie Group, ResMed, WiseTech Global, and Xero. The Motley Fool Australia has positions in and has recommended Macquarie Group, ResMed, WiseTech Global, and Xero. The Motley Fool Australia has recommended Cochlear. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A panel of four judges hold up cards all showing the perfect score of ten out of ten
Growth Shares

10 excellent ASX shares to buy in May

Here is a selection of high-quality shares that could be in the buy zone this month.

Read more »

Man with a rocket strapped to his back on a tiny bicycle ready to take off.
Growth Shares

2 ASX shares tipped to grow 90% or more in the next 12 months!

These stocks have the potential to deliver major returns!

Read more »

Young businesswoman sitting in kitchen and working on laptop.
Growth Shares

Down 67%, is this ASX 300 share a bargain buy?

A sharp share price decline has reset expectations, but the underlying growth story and market opportunity have not changed.

Read more »

A man and woman sit next to each other looking at each other and feeling excited and surprised after reading good news about their shares on a laptop.
Growth Shares

2 high-quality ASX 200 shares experts rate as buys

These stocks are top-rated by some of Australia’s top brokers.

Read more »

Person holding Australian dollar notes, symbolising dividends.
Growth Shares

3 amazing ASX 200 shares to buy with $5,000 in May

Analysts are recommending these ASX 200 shares as buys.

Read more »

woman accessing her smart home from her phone
Growth Shares

This beaten-down ASX 200 growth stock could be one to watch

Demand for data centres is accelerating, but earnings are yet to catch up. That gap could define the opportunity from…

Read more »

A kid stretches up to reach the top of the ruler drawn on the wall behind.
Growth Shares

2 top ASX shares to buy and hold for the next decade

I really like these investments for the long term.

Read more »

A woman hangs from a cliff with raging waters below.
Growth Shares

The ASX's hottest shares just stumbled — warning sign?

Are expectations starting to outpace fundamentals?

Read more »